Earlier this month, the federal Advisory Committee on Immunization Practices (ACIP) recommended the Tdap (tetanus-diphtheria-acellular pertussis) vaccine for all adults, including those aged 65 and older. Previously, the vaccine was recommended for those 19 through 64 years old and for adults 65 and older in close contact with young infants. The new guidance calls for all adults 19 and older who have not received the Tdap vaccine already to be given a single dose, according to IDSA’s ACIP liaison, Kathleen M. Neuzil, MD, MPH, FIDSA.
The committee also heard updates on the current influenza season, which is fairly mild at present, although there is increased activity in certain areas. The new 13-valent pneumococcal conjugate vaccine (PCV13), recently approved for use in adults, was also discussed, but no recommendations were made.
ACIP recommendations become official once approved by the CDC and published in MMWR.
< Previous Article | Next Article >